0
Article |

"Enclosed" Hemorrhage and Neonatal Jaundice FREE

AARON R. RAUSEN, M.D.; LOUIS K. DIAMOND, M.D.
[+] Author Affiliations

Submitted for publication March 2, 1960.

300 Longwood Ave. (15).

This study was supported by Grant B-264 from the National Institutes of Health.


Am J Dis Child. 1961;101(2):164-169. doi:10.1001/archpedi.1961.04020030028006.
Text Size: A A A
Published online

Hyperbilirubinemia in the newborn, regardless of the cause, is a potentially dangerous state. If the serum indirect bilirubin exceeds 20 mg. %, the possibility of kernicterus is significant; the higher the bilirubin, the greater the risk of this central nervous system damage.

Many conditions and combinations of circumstances have been noted to be associated with hyperbilirubinemia in the newborn, the commonest cause being hemolytic disease of the newborn due to blood group incompatibility. Other, less common, causes include prematurity, sepsis, excessive administration of certain drugs to the mother at term or to the newborn, congenital spherocytic and nonspherocytic hemolytic anemias, and the Crigler-Najjar syndrome.

Recently, 3 newborn infants were seen with hemorrhage into their tissues, in whom significant hyperbilirubinemia developed. The hemorrhage produced an increased amount of bilirubin as the hemoglobin "enclosed" in the tissues broke down. The exposure to an excess bilirubin load, occurring at a time of life when

REFERENCES

Allen, F. H., Jr., and Diamond, L. K.: Erythroblastosis Fetalis, Including Exchange Transfusion Technique , Boston, Little, Brown & Company, 1957;, p. 44.
Day, R., and Johnson, L.:  Kernicterus , in Progress in Hematology , edited by L. M. Tocantins, New York, Grune & Stratton, Inc., 1959;, Vol. 2, p. 133.
Arias, I. M.:  Recent Progress in the Understanding of Bilirubin Metabolism and Jaundice , New York J. Med. 59:3759, 1959;.
Dancis, J.:  Aspects of Bilirubin Metabolism—Before and After Birth , Pediatrics 24:980, 1959;.
Brown, A. K., and Zuelzer, W. W.:  Studies on Hyperbilirubinemia: I. Hyperbilirubinemia of the Newborn Unrelated to Isoimmunization , Am. J. Dis. Child. 93:263, 1957;.
Wheeler, W. E., and Ambuel, J. P.:  The Efficient Use of Exchange Transfusions in the Treatment of Erythroblastosis , Pediat. Clin. North America , p. 383, (May) , 1957;.
Lathe, G. H., and Walker, M.:  Inhibition of Bilirubin Conjugation in Rat Liver Slices by Human Pregnancy and Neonatal Serum and Steroids , Quart. J. Exper. Physiol. 43:257, 1958;.
Hsia, D. Y. Y.; Dowben, R. M.; Shaw, R., and Grossman, A.: The Inhibition of Glucuronyl Transferase by Progestational Agents from Pregnant Serum, presented at the Annual Meeting of the Society for Pediatric Research, May 3 and 4, 1960.
Lucey, J. F.; Arias, I. M., and McKay, R. J., Jr.: Transient Familial Neonatal Hyperbilirubinemia, presented at the Annual Meeting of the American Pediatric Society, May 5-6, 1960.
Meyer, T. C., and Angus, J.:  Effect of Large Doses of "Synkavit" in the Newborn , Arch. Dis. Childhood 31:212, 1956;.
Silverman, W. A.; Andersen, D. H.; Blanc, W. A., and Crozier, D. N.:  A Difference in Mortality Rate and Incidence of Kernicterus Among Premature Infants Allotted to 2 Prophylactic Antibacterial Regimens , Pediatrics 18:614, 1956;.
Odell, G. B.:  Studies in Kernicterus: I. The Protein Binding of Bilirubin , J. Clin. Invest. 38: 823, 1959;.
Benirschke, K.: Unpublished observations.
Farber, S., and Vawter, G. F.:  Clinical Pathological Conference , J. Pediat. 56:308, 1960;

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Allen, F. H., Jr., and Diamond, L. K.: Erythroblastosis Fetalis, Including Exchange Transfusion Technique , Boston, Little, Brown & Company, 1957;, p. 44.
Day, R., and Johnson, L.:  Kernicterus , in Progress in Hematology , edited by L. M. Tocantins, New York, Grune & Stratton, Inc., 1959;, Vol. 2, p. 133.
Arias, I. M.:  Recent Progress in the Understanding of Bilirubin Metabolism and Jaundice , New York J. Med. 59:3759, 1959;.
Dancis, J.:  Aspects of Bilirubin Metabolism—Before and After Birth , Pediatrics 24:980, 1959;.
Brown, A. K., and Zuelzer, W. W.:  Studies on Hyperbilirubinemia: I. Hyperbilirubinemia of the Newborn Unrelated to Isoimmunization , Am. J. Dis. Child. 93:263, 1957;.
Wheeler, W. E., and Ambuel, J. P.:  The Efficient Use of Exchange Transfusions in the Treatment of Erythroblastosis , Pediat. Clin. North America , p. 383, (May) , 1957;.
Lathe, G. H., and Walker, M.:  Inhibition of Bilirubin Conjugation in Rat Liver Slices by Human Pregnancy and Neonatal Serum and Steroids , Quart. J. Exper. Physiol. 43:257, 1958;.
Hsia, D. Y. Y.; Dowben, R. M.; Shaw, R., and Grossman, A.: The Inhibition of Glucuronyl Transferase by Progestational Agents from Pregnant Serum, presented at the Annual Meeting of the Society for Pediatric Research, May 3 and 4, 1960.
Lucey, J. F.; Arias, I. M., and McKay, R. J., Jr.: Transient Familial Neonatal Hyperbilirubinemia, presented at the Annual Meeting of the American Pediatric Society, May 5-6, 1960.
Meyer, T. C., and Angus, J.:  Effect of Large Doses of "Synkavit" in the Newborn , Arch. Dis. Childhood 31:212, 1956;.
Silverman, W. A.; Andersen, D. H.; Blanc, W. A., and Crozier, D. N.:  A Difference in Mortality Rate and Incidence of Kernicterus Among Premature Infants Allotted to 2 Prophylactic Antibacterial Regimens , Pediatrics 18:614, 1956;.
Odell, G. B.:  Studies in Kernicterus: I. The Protein Binding of Bilirubin , J. Clin. Invest. 38: 823, 1959;.
Benirschke, K.: Unpublished observations.
Farber, S., and Vawter, G. F.:  Clinical Pathological Conference , J. Pediat. 56:308, 1960;

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.